Jesse Fryk
Jesse Fryk
Details
Role
Epidemiologist
Research area
Infection, Immunity and Global Health
Group
Epidemiology Informatics
Contact
Email
show email address
Mr Jesse Fryk is an Epidemiologist with Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC) and the Health Informatics team under the direction of Prof. Jim Buttery. His role includes the routine analysis and reporting of adverse events following vaccination (AEFI) for COVID-19 and non-COVID-19 vaccines, and assists with prepare documentation for findings and recommendations that may facilitate change in vaccination practices and policy. Jesse is also involved with a research project examining vaccine safety and effectiveness of COVID-19 and Influenza vaccines in the aged care facility setting, known as COVIRAC.
Prior to his appointment at MCRI, Jesse had worked as a researcher for the Australian Red Cross Blood Service in Brisbane, under the direction of Dr. Helen Faddy and Prof. Robert Flower. The research Jesse was involved with focussed on blood safety and donor safety - understanding the prevalence (active, recent and past infection) of infectious diseases not typically screened by the Blood Service, the risk of transfusion-transmission to a recipient, and exploring proactive and reactive approaches to mitigate this risk while permitting clinical use of the implicated blood and blood products.
Prior to his appointment at MCRI, Jesse had worked as a researcher for the Australian Red Cross Blood Service in Brisbane, under the direction of Dr. Helen Faddy and Prof. Robert Flower. The research Jesse was involved with focussed on blood safety and donor safety - understanding the prevalence (active, recent and past infection) of infectious diseases not typically screened by the Blood Service, the risk of transfusion-transmission to a recipient, and exploring proactive and reactive approaches to mitigate this risk while permitting clinical use of the implicated blood and blood products.
Mr Jesse Fryk is an Epidemiologist with Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC) and the Health Informatics team under the direction of Prof. Jim Buttery. His role includes the routine analysis and reporting of...
Mr Jesse Fryk is an Epidemiologist with Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC) and the Health Informatics team under the direction of Prof. Jim Buttery. His role includes the routine analysis and reporting of adverse events following vaccination (AEFI) for COVID-19 and non-COVID-19 vaccines, and assists with prepare documentation for findings and recommendations that may facilitate change in vaccination practices and policy. Jesse is also involved with a research project examining vaccine safety and effectiveness of COVID-19 and Influenza vaccines in the aged care facility setting, known as COVIRAC.
Prior to his appointment at MCRI, Jesse had worked as a researcher for the Australian Red Cross Blood Service in Brisbane, under the direction of Dr. Helen Faddy and Prof. Robert Flower. The research Jesse was involved with focussed on blood safety and donor safety - understanding the prevalence (active, recent and past infection) of infectious diseases not typically screened by the Blood Service, the risk of transfusion-transmission to a recipient, and exploring proactive and reactive approaches to mitigate this risk while permitting clinical use of the implicated blood and blood products.
Prior to his appointment at MCRI, Jesse had worked as a researcher for the Australian Red Cross Blood Service in Brisbane, under the direction of Dr. Helen Faddy and Prof. Robert Flower. The research Jesse was involved with focussed on blood safety and donor safety - understanding the prevalence (active, recent and past infection) of infectious diseases not typically screened by the Blood Service, the risk of transfusion-transmission to a recipient, and exploring proactive and reactive approaches to mitigate this risk while permitting clinical use of the implicated blood and blood products.
Top Publications
- Speicher, DJ, Fryk, JJ, Kashchuk, V, Faddy, HM, Johnson, NW. Human Herpesvirus 8 in Australia: DNAemia and Cumulative Exposure in Blood Donors.. Viruses 14(10) : 2022 view publication
- Fryk, JJ, Tong, S, Marshall, C, Rajkhowa, A, Buising, K, MacIsaac, C, Walsham, N, Thevarajan, I. Knowledge, attitudes and practices of healthcare workers within an Australian tertiary hospital to managing high-consequence infectious diseases.. Infect Dis Health 26(2) : 95 -103 2021 view publication
- Faddy, HM, Fryk, JJ, Hall, RA, Young, PR, Reichenberg, S, Tolksdorf, F, Sumian, C, Gravemann, U, Seltsam, A, Marks, DC. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light.. Transfusion 59(7) : 2223 -2227 2019 view publication
- Fryk, JJ, Marks, DC, Hobson-Peters, J, Watterson, D, Hall, RA, Young, PR, Reichenberg, S, Tolksdorf, F, Sumian, C, Gravemann, U, et al. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light.. Transfusion 57(11) : 2677 -2682 2017 view publication
- Hoad, VC, Seed, CR, Fryk, JJ, Harley, R, Flower, RLP, Hogema, BM, Kiely, P, Faddy, HM. Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment.. Vox Sang 112(7) : 614 -621 2017 view publication
Page 1 of 3